title: Immunostaining of phospho-histone H3 and Ki-67 improves reproducibility of recurrence risk assessment of gastrointestinal stromal tumors.
abstract: Gastrointestinal stromal tumors (GISTs) are the most common non-epithelial tumors in the digestive tract. Beyond surgery, therapeutic management depends on risk of recurrence. Risk evaluation of GIST takes into account location and size of the tumor, whether or not the tumor was intact or ruptured and mitotic index. The mitotic index lacks in intra- and interobserver reproducibility. In this study, we evaluated on 61 GISTs, the reproducibility of mitotic counting using classical hematoxylin-eosin-saffron (HES) staining, and its correlation with the mitotic count obtained through immunohistochemical staining for phospho-histone H3 (PHH3) and the proliferation index based upon Ki-67 immunostaining. Mitotic counts by HES and PHH3 staining and Ki-67 proliferation index were evaluated twice by three independent observers taking into account interpretation times per tumor for each technique. HES-based and PHH3-based mitotic counts and Ki-67 proliferation index correlated well and presented good intra- and interobserver reproducibility. PHH3 staining resulted in a slight but statistically significant difference of about two more mitotic figures per 5 mm(2) than the HES-based count, which might have put some borderline tumors in a different risk category. Immunohistochemical staining for PHH3 and Ki-67 allowed more rapid interpretation than mitotic counts based upon HES staining, but only PHH3 staining allows counting of mitoses. Immunostaining using anti-PHH3 and anti-Ki-67 antibodies will eventually provide improved recurrence risk stratification of GIST and may become effective ancillary tools in deciding on optimal therapeutic management.
authors.affiliation: Service d'Anatomie et Cytologie Pathologiques, CHRU Brest, 29220, Brest, France, arnaud.uguen@chu-brest.fr.
authors.forename: Arnaud
authors.initials: A
authors.lastname: Uguen
authors.forename: Gwenaël
authors.initials: G
authors.lastname: Conq
authors.forename: Laurent
authors.initials: L
authors.lastname: Doucet
authors.forename: Matthieu
authors.initials: M
authors.lastname: Talagas
authors.forename: Sebastian
authors.initials: S
authors.lastname: Costa
authors.forename: Marc
authors.initials: M
authors.lastname: De Braekeleer
authors.forename: Pascale
authors.initials: P
authors.lastname: Marcorelles
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D005770:Gastrointestinal Neoplasms / Q000209:etiology* / Q000473:pathology; D046152:Gastrointestinal Stromal Tumors / Q000209:etiology* / Q000473:pathology; D006657:Histones / Q000032:analysis*; D006801:Humans; D007150:Immunohistochemistry; D019394:Ki-67 Antigen / Q000032:analysis*; D008297:Male; D008875:Middle Aged; D008938:Mitosis; D010766:Phosphorylation; D015203:Reproducibility of Results; D018570:Risk Assessment
chemical_list: D006657:Histones; D019394:Ki-67 Antigen
references.citation: Mod Pathol. 2014 Sep;27(9):1246-54
references.pmid: 24434900
references.citation: Cytometry. 1998 Jun 1;32(2):71-7
references.pmid: 9627219
references.citation: Int J Gynecol Pathol. 2009 Jul;28(4):316-21
references.pmid: 19483635
references.citation: Acta Ophthalmol. 2011 Mar;89(2):e155-60
references.pmid: 19900200
references.citation: Histopathology. 2010 Aug;57(2):259-70
references.pmid: 20716168
references.citation: Hum Pathol. 2008 Oct;39(10):1411-9
references.pmid: 18774375
references.citation: Curr Treat Options Oncol. 2012 Sep;13(3):277-84
references.pmid: 22743760
references.citation: World J Gastroenterol. 2012 Apr 14;18(14 ):1664-71
references.pmid: 22529697
references.citation: Ann Oncol. 2012 Nov;23(11):2776-81
references.pmid: 22831984
references.citation: Gastroenterol Clin North Am. 2013 Jun;42(2):399-415
references.pmid: 23639648
references.citation: J Clin Oncol. 2005 Aug 10;23(23):5357-64
references.pmid: 15928335
references.citation: J Natl Cancer Inst. 2013 Dec 18;105(24):1897-906
references.pmid: 24203987
references.citation: Am J Surg Pathol. 2006 May;30(5):657-64
references.pmid: 16699322
references.citation: Int J Cancer. 2005 Nov 1;117(2):289-93
references.pmid: 15900576
references.citation: Am J Clin Pathol. 2011 Aug;136(2):252-9
references.pmid: 21757598
references.citation: Int J Surg Pathol. 2002 Apr;10(2):81-9
references.pmid: 12075401
references.citation: Eur J Cancer. 2006 May;42(8):1093-103
references.pmid: 16624552
references.citation: Am J Dermatopathol. 2010 Oct;32(7):650-4
references.pmid: 20559123
references.citation: Brain Tumor Pathol. 2009;26(2):51-7
references.pmid: 19856215
references.citation: J Biol Chem. 1998 Sep 18;273(38):24470-8
references.pmid: 9733739
references.citation: Nature. 1995 Jan 26;373(6512):347-9
references.pmid: 7530333
references.citation: Semin Diagn Pathol. 2006 May;23(2):70-83
references.pmid: 17193820
references.citation: Chromosoma. 1997 Nov;106(6):348-60
references.pmid: 9362543
references.citation: Hum Pathol. 2002 Jan;33(1):111-5
references.pmid: 11823981
references.citation: Appl Immunohistochem Mol Morphol. 2006 Mar;14(1):46-51
references.pmid: 16540730
references.citation: World J Gastroenterol. 2012 May 28;18(20):2569-75
references.pmid: 22654456
references.citation: Nat Rev Cancer. 2011 Nov 17;11(12):865-78
references.pmid: 22089421
references.citation: Cancer Res. 2001 Nov 15;61(22):8118-21
references.pmid: 11719439
references.citation: Am J Surg Pathol. 2013 Jun;37(6):882-9
references.pmid: 23629443
references.citation: J Cutan Pathol. 2013 Jun;40(6):557-63
references.pmid: 23550775
references.citation: Oncol Lett. 2014 Mar;7(3):745-749
references.pmid: 24527082
references.citation: Mod Pathol. 2007 Dec;20(12):1307-15
references.pmid: 17917671
references.citation: Ann Diagn Pathol. 2000 Aug;4(4):228-35
references.pmid: 10982300